Similar articles for PMID: 17456761

Year	Number of Results
1987	1
1989	1
1992	2
1996	1
1997	2
1998	1
1999	1
2000	2
2001	3
2002	3
2003	2
2004	3
2005	5
2006	10
2007	7
2008	7
2009	8
2010	5
2011	6
2012	4
2013	6
2014	4
2015	6
2016	6
2017	5
2018	7
2019	4
2020	1
2021	3
2022	2
2023	1
2024	0

1

Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity.

Shekhar MP, Santner S, Carolin KA, Tait L. Shekhar MP, et al. Am J Pathol. 2007 May;170(5):1546-60. doi: 10.2353/ajpath.2007.061004. Am J Pathol. 2007. PMID: 17456761 Free PMC article.

2

Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.

Yuan J, Liu M, Yang L, Tu G, Zhu Q, Chen M, Cheng H, Luo H, Fu W, Li Z, Yang G. Yuan J, et al. Breast Cancer Res. 2015 May 21;17(1):69. doi: 10.1186/s13058-015-0579-y. Breast Cancer Res. 2015. PMID: 25990368 Free PMC article.

3

Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.

Knowlden JM, Hutcheson IR, Barrow D, Gee JM, Nicholson RI. Knowlden JM, et al. Endocrinology. 2005 Nov;146(11):4609-18. doi: 10.1210/en.2005-0247. Epub 2005 Jul 21. Endocrinology. 2005. PMID: 16037379

4

Estrogen receptor-α variant, ER-α36, is involved in tamoxifen resistance and estrogen hypersensitivity.

Zhang X, Wang ZY. Zhang X, et al. Endocrinology. 2013 Jun;154(6):1990-8. doi: 10.1210/en.2013-1116. Epub 2013 Apr 1. Endocrinology. 2013. PMID: 23546601

5

Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.

Hutcheson IR, Knowlden JM, Madden TA, Barrow D, Gee JM, Wakeling AE, Nicholson RI. Hutcheson IR, et al. Breast Cancer Res Treat. 2003 Sep;81(1):81-93. doi: 10.1023/A:1025484908380. Breast Cancer Res Treat. 2003. PMID: 14531500

6

Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.

Chang HL, Sugimoto Y, Liu S, Wang LS, Huang YW, Ye W, Lin YC. Chang HL, et al. Anticancer Res. 2009 Aug;29(8):3195-205. Anticancer Res. 2009. PMID: 19661335 Free article.

7

Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells.

Fan P, Wang J, Santen RJ, Yue W. Fan P, et al. Cancer Res. 2007 Feb 1;67(3):1352-60. doi: 10.1158/0008-5472.CAN-06-1020. Cancer Res. 2007. PMID: 17283173

8

Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.

Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, Lin YC. Chang HL, et al. Anticancer Res. 2006 May-Jun;26(3A):1773-84. Anticancer Res. 2006. PMID: 16827106 Free article.

9

Activation function-1 domain of estrogen receptor regulates the agonistic and antagonistic actions of tamoxifen.

Glaros S, Atanaskova N, Zhao C, Skafar DF, Reddy KB. Glaros S, et al. Mol Endocrinol. 2006 May;20(5):996-1008. doi: 10.1210/me.2005-0285. Epub 2006 Feb 2. Mol Endocrinol. 2006. PMID: 16455819 Retracted.

10

EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer.

Zhang Y, Su H, Rahimi M, Tochihara R, Tang C. Zhang Y, et al. Int J Cancer. 2009 Nov 1;125(9):2021-8. doi: 10.1002/ijc.24540. Int J Cancer. 2009. PMID: 19588487 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

105 results

Results by year